Clinical trial
A Multi-center, Randomized, Double-blind, Double-simulation, Duloxetine Hydrochloride Enteric-coated Positive-control Phase III Study of Desvenlafaxine Succinate Sustained-Release in the Treatment of Major Depressive Disorder.
NCT04364997 is registered in ClinicalTrials.gov with CSPC ZhongQi Pharmaceutical Technology Co., Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, Randomized, Double-blind, Double-simulation, Duloxetine Hydrochloride Enteric-coated Positive-control Phase III Study of Desvenlafaxine Succinate Sustained-Release in the Treatment of Major Depressive Disorder.
- Lead sponsor
- CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- June 18, 2020
- Completion date
- September 22, 2021
- Enrollment
- 420 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.